Tag Archives: bermudian insurers

Hot Take-outs

In many episodes of fervent investment activity within a particular hot spot, like the current insurance M&A party, there is a point where you think “really?”. The deal by Mitsui Sumitomo to take over Amlin at 2.4 times tangible book is one such moment. A takeover of Amlin was predicted by analysts, as per this post, so that’s no surprise but the price is.

With the usual caveat on the need to be careful when comparing multiples for US, Bermuda, London and European insurers given the different accounting standards, the graph below from a December post, shows the historical tangible book value levels and the improving multiples being applied by the market to London firms such as Amlin.

click to enlargeHistorical Tangible Book Multiples for Reinsurers & Specialty Insurers

Comparable multiples from recent deals, as per the graph below, show the high multiple of the Mitsui/Amlin deal. Amlin has a 10 year average ROE around 20% but a more realistic measure is the recent 5 year average of 11%. In today’s market, the short to medium term ROE expectation is likely to be in the high single digits. Even at 10%, the 2.4 multiple looks aggressive.

click to enlargeM&A Tangible Book Multiples September 2015

There is little doubt that the insurance M&A party will continue and that the multiples may be racy. In the London market, the remaining independent players are getting valued as such, as per the graph below tracking valuations at points in time.

click to enlargeLondon Specialty Insurers Tangible Book Values

When the hangover comes, a 2.4 multiple will look even sillier than its does now at this point in the pricing cycle. In the meantime, its party like 1999 time!

Insurers keep on swinging

In a previous post, I compared the M&A action in the reinsurance and specialty insurance space to a rush for the bowl of keys in a swingers party. Well, the ACE/Chubb deal has brought the party to a new level where anything seems possible. The only rule now seems to be a size restriction to avoid a G-SIFI label (although MetLife and certain US stakeholders are fighting to water down those proposals for insurers).

I expanded the number of insurers in my pool for an update of the tangible book multiples (see previous post from December) as per the graphic below. As always, these figures come with a health warning in that care needs to be taken when comparing US, European and UK firms due to the differing accounting treatment (for example I have kept the present value of future profits as a tangible item). I estimated the 2015 ROE based upon Q1 results and my view of the current market for the 2011 to 2015 average.

click to enlargeReinsurers & Specialty Insurers NTA Multiples July 2015

I am not knowledgeable enough to speculate on who may be the most likely next couplings (for what its worth, regular readers will know I think Lancashire will be a target at some stage). This article outlines who Eamonn Flanagan at Shore Capital thinks is next, with Amlin being his top pick. What is clear is that the valuation of many players is primarily based upon their M&A potential rather than the underlying operating results given pricing in the market. Reinsurance pricing seems to have stabilised although I suspect policy terms & conditions remains an area of concern. On the commercial insurance side, reports from market participants like Lockton (see here) and Towers Watson (see graph below) show an ever competitive market.

click to enlargeCommercial Lines Insurance Pricing Survey Towers Watson Q1 2015

Experience has thought me that pricing is the key to future results for insurers and, although the market is much more disciplined than the late 1990s, I think many will be lucky to produce double-digit ROEs in the near term on an accident year basis (beware those dipping too much into the reserve pot!).

I am also nervous about the amount of unrealised gains which are inflating book values that may reverse when interest rates rise. For example, unrealised gains make up 8%, 13% and 18% of the Hartford, Zurich, and Swiss Re’s book value respectively as at Q1. So investing primarily to pick up an M&A premium seems like a mugs game to me in the current market.

M&A obviously brings considerable execution risk which may result in one plus one not equalling two. Accepting that the financial crisis hit the big guys like AIG and Hartford pretty hard, the graph below suggests that being too big may not be beautiful where average ROE (and by extension, market valuation) is the metric for beauty.

click to enlargeIs big beautiful in insurance

In fact, the graph above suggests that the $15-$25 billion range in terms of premiums may be the sweet spot for ROE. Staying as a specialist in the $2-7 billion premium range may have worked in the past but, I suspect, will be harder to replicate in the future.

Updated Insurance Multiples

It has been a while since I looked at net tangible asset multiples for reinsurers and selected specialty insurers (the last such post is here). Motivated by the collapse in Lancashire’s multiple (briefly mentioned in a previous post) since they went ex-dividend, I redid the tangible book multiple figures. Previously I have used average operating ROEs as the x-axis but this time I have used annualized total returns since year-end 2010 (to capture the 2011 catastrophe year with the recent results of the past 3 years). Annualized total returns are made up of tangible book growth and dividends paid in 2011 to today. The split between tangible book growth and dividends, on an annualized basis across the past 4 years, for each firm as per the graph below (when calculating tangible book values, as is my usual practise disclosed previously, I excluded all goodwill and intangibles, except for the present value of future profits (PVFP) for life reinsurance business for European reinsurers).

click to enlargeReinsurers & Specialty Insurer Total Return December 2014

The graph of tangible book multiples to annualized returns is below. [Note – although insurance accounting has converged somewhat in recent years, caution still needs to be taken when comparing UK, European, and Bermudian/US firms due to the differing accounting regimes under which results are reported].

click to enlargeReinsurers & Specialty Insurers NTA Multiples December 2014

I split the firms into different colours – green is for the Bermudian & US firms, red is for London market firms, and blue is for the European composite reinsurers. In terms of who else may get involved in M&A following the Renaissance/Platinum deal, its interesting to see most of the Bermudians bunched up so close to each other in valuation and return profiles. The higher valued and larger firms may be the instigators in taking over smaller competitors but it looks more likely that medium sized firms need to get with today’s realities and seek tie-ups together. Who will wait it out in the hope of some market changing event or who will get it together in 2015 will be fascinating to watch!!

Follow-on: To get an idea of historical changes in the tangible book multiples in the three groupings above, the graph below shows the trends. The multiples in each year are simple averages across the firms (and not all are at the same point in the year) but the graph nonetheless gives an idea of changing market sentiment. Although the London and European firms are a smaller sample than the Bermudian/US firms, the graph indicates that the market is confident that the underwriting indiscipline of years past have been overcome in the London market, thus justifying a premium multiple. Time will tell on that score…..

click to enlargeHistorical Tangible Book Multiples for Reinsurers & Specialty Insurers

Relative valuations of selected reinsurers and wholesale insurers

It’s been a great 12 months for wholesale insurers with most seeing their share price rise by 20%+, some over 40%. As would be expected, there has been some correlation between the rise in book values and the share price increase although market sentiment to the sector and the overall market rally have undoubtedly also played their parts. The graph below shows the movements over the past 12 months (click to enlarge).

12 month share price change selected reinsurers March 2013The price to tangible book is one of my preferred indicators of value although it has limitations when comparing companies reporting under differing accounting standards & currencies and trading in different exchanges. The P/TBV valuations as at last weekend are depicted in the graph below. The comments in this post are purely made on the basis of the P/TBV metric calculated from published data and readers are encouraged to dig deeper.

I tend to look at the companies relative to each other in 4 broad buckets – the London market firms, the continental European composite reinsurers, the US/Bermuda firms, and the alternative asset or “wannabe buffet” firms.  Comparisons across buckets can be made but adjustments need to be made for factors such as those outlined in the previous paragraph. Some firms such as Lancashire actually report in US$ as that is where the majority of their business is but trade in London with sterling shares. I also like to look at the relative historical movements over time & the other graph below from March 2011 helps in that regard.

Valuations as at March 2013 (click to enlarge):

Price to net tangible book & 5 year average ROE reinsurers March 2013

Valuations as at March 2011 (click to enlarge):

Price to net tangible book & 5 year average ROE reinsurers March 2011 The London market historically trades at the highest multiples – Hiscox, Amlin, & Lancashire are amongst the leaders, with Catlin been the poor cousin. Catlin’s 2012 operating results were not as strong as the others but the discount it currently trades at may be a tad unfair. In the interest of open disclosure, I must admit to having a soft spot for Lancashire. Their consistent shareholder friendly actions result in the high historical valuation. These actions and a clear communication of their straight forward business strategy shouldn’t distract investors from their high risk profile. The cheeky way they present their occurrence PMLs in public disclosures cannot hide their high CAT exposures when the occurrence PMLs are compared to their peers on a % of tangible asset basis. Their current position relative to Hiscox and Amlin may be reflective of this (although they tend to go down when ex dividend, usually a special dividend!).

Within the continental European composite reinsurer bucket, the Munich and Swiss, amongst others, classify chunky amounts of present value of future profits from their life business as an intangible. As this item will be treated as capital under Solvency II, further metrics need to be considered when looking at these composite reinsurers. The love of the continental Europeans of hybrid capital and the ability to compare the characteristics of the varying instruments is another factor that will become clearer in a Solvency II world. Compared to 2011 valuations Swiss Re has been a clear winner. It is arguable that the Munich deserves a premium given it’s position in the sector.

The striking thing about the current valuations of the US/Bermudian bucket is how concentrated they are, particularly when compared to 2011. The market seems to be making little distinction between the large reinsurers like Everest and the likes of Platinum & Montpelier. That is surely a failure of these companies to distinguish themselves and effectively communicate their differing business models & risk profiles.

The last bucket is the most eccentric. I would class firms such as Fairfax  in this bucket. Although each firm has its own twist, generally these companies are interested in the insurance business as the provider of cheap “float”, a la Mr Buffet, with the focus going into the asset side. Generally, their operating results are poorer than their peers and they have a liking for the longer tail business if the smell of the float is attractive enough (which is difficult with today’s interest rate). This bucket really needs to be viewed through different metrics which we’ll leave for another day.

Overall then, the current valuations reflect an improved sentiment on the sector. Notwithstanding the musings above, nothing earth shattering stands out based solely on a P/TBV analysis.  The ridiculously low valuations of the past 36 months aren’t there anymore. My enthusiasm for the sector is tempered by the macro-economic headwinds, the overall run-up in the market (a pull-back smells inevitable), and the unknown impact upon the sector of the current supply distortions from yield seeking capital market players entering the market.